Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.29 USD | +4.15% | +34.89% | +0.27% |
Business Summary
Number of employees: 14
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
INKmune and DN-TNF Product Platform
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -58.56% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -58.56% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Moss
FOU | Founder | 54 | 15-08-31 |
Mark Lowdell
FOU | Founder | 61 | 15-08-31 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Tara Lehner
CTO | Chief Tech/Sci/R&D Officer | - | - |
General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marcia Allen
BRD | Director/Board Member | 73 | 19-11-18 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Scott Juda
BRD | Director/Board Member | 53 | 18-03-12 |
Director/Board Member | 64 | 19-08-07 | |
J. Ganjei
BRD | Director/Board Member | 50 | 16-08-31 |
David Moss
FOU | Founder | 54 | 15-08-31 |
Director/Board Member | 66 | 16-11-30 | |
Mark Lowdell
FOU | Founder | 61 | 15-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,774,985 | 12,431,761 ( 66.21 %) | 0 | 66.21 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.27% | 212M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- INMB Stock
- Company INmune Bio, Inc.